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eMethods. Fluid Biomarkers, Genetics, and Neuroimaging
Fluid biomarkers: We processed non-fasting blood and CSF samples using standardised protocols and stored 0.5ml aliquots at -80°C within 60 minutes of sample collection. We measured serum NF-L using an ultrasensitive single molecule array (Simoa) assay. 1 In addition, where available, CSF samples from cases were tested for total tau (T-tau) and Aβ1-42 levels (INNOTEST ELISA -Fujirebio Europe N.V., Gent, Belgium). 2 A subset of PD cases from the Tracking Parkinson's study underwent baseline serum NF-L testing using the Simoa assay. Neuroimaging: Scan protocols were designed at the outset of the study to closely match across centres, based on the international Genetic Frontotemporal Dementia Initiative protocols (MP-RAGE, TR 2s, TE 2.93ms, Flip angle 8deg, 1.1mm isotropic). 6 T1-weighted images were processed using the recon-all pipeline with brainstem structures of FreeSurfer v6.0.0 (surfer.nmr.mgh.harvard.edu) into subcortical segments and cortical surface parcellations. Regional analyses were performed using volume measures from 68 Desikan-Killiany atlas cortical regions and 38 subcortical volume measures from the segmentation. 7, 8 We combined volume measures from the parcellation to calculate cortical grey matter volumes of the frontal, temporal, parietal, occipital lobes. Hippocampi and amygdalae volumes are included in the temporal lobe data. The remaining segmentation regions were combined into central structures (basal ganglia, thalamus, accumbens), cerebellar grey matter, brainstem, and ventricles. The images were additionally segmented into grey, white and CSF modulated probability maps using CAT12 (neuro.uni-jena.de/cat) in order to obtain total intracranial volume (TIV) measures. We also calculated the ratio of the pons to midbrain volume.
Genetics
